First targeted therapy for cholangiocarcinoma shows clinical benefit in phase III trial
ESMO 2019 Congress, Sept. 27 -- Oct. 1, Barcelona, SpainCredit: © European Society for Medical Oncology Barcelona, Spain, 30 September ...
ESMO 2019 Congress, Sept. 27 -- Oct. 1, Barcelona, SpainCredit: © European Society for Medical Oncology Barcelona, Spain, 30 September ...
ESMO 2019 Congress, Sept. 27 -- Oct. 1, Barcelona, SpainCredit: European Society for Medical Oncology Barcelona, Spain, 28 September 2019 ...
World's leading experts gather in Seville to discuss the fastest growing health epidemic in Europe now affecting 1 in 4 ...
Research on LRRK2 gene in mice could lead to new treatments, preventionCredit: The Ottawa Hospital Researchers have struggled for years ...
UToledo research adds to evidence that new exposure guidelines for microcystin may be needed for those with liver disease or ...
Blood flukes and Helicobacter pylori: co-infection changes immune responseCredit: Clarissa Prazeres da Costa / TUM A team at the Technical ...
Case Western Reserve School of Medicine and University Hospitals Cleveland Medical Center researcher receives NIH funding to investigateCredit: Case Western ...
The pill is the first known working device capable of non-invasively and accurately assessing the profile of bacterial species inhabiting ...
Caltech researchers demonstrate a robotic platform for delivering drugs in the human bodyCredit: Caltech Targeting medical treatment to an ailing ...
Even without symptoms or antibiotic use, these virulent and multi-drug resistant strains are carried in the gut for long timeCredit: ...
Credit: ECU People who follow the paleo diet have twice the amount of a key blood biomarker linked closely to ...
Large VA study reveals diagnostic potential of random plasma glucose testsCredit: Lisa Pessin Random plasma glucose tests could be used ...
(Boston)--Michelle Long, MD, MSc, assistant professor of medicine at Boston University School of Medicine (BUSM) has been awarded a three-year, ...
Bentham Science ongoing book series continues to bring more updates anti-angiogenesis drug targets. This volume brings together 7 reviews on ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.